Importance of dose in palliative treatment for incurable head and neck cancer with radiotherapy

To identify predictors of palliation for head and neck cancer treated with the “Hypo Trial” hypofractionated radiation therapy regimen in a clinical setting.

[1]  Versione,et al.  Common Terminology Criteria for Adverse Events , 2020, Definitions.

[2]  A. Lin,et al.  Palliative radiation therapy for head and neck cancers. , 2019, International journal of radiation oncology, biology, physics.

[3]  V. Paleri,et al.  Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A systematic review. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  A. Bujold,et al.  Palliative Radiation Therapy for Advanced Head and Neck Carcinomas: A Phase 2 Study. , 2016, International journal of radiation oncology, biology, physics.

[5]  N. Lee,et al.  Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers. , 2015, Oral oncology.

[6]  E. Cohen,et al.  Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  E. Touboul,et al.  Hypofractionated palliative radiotherapy for advanced head and neck cancer: The IHF2SQ regimen , 2013, Head & neck.

[8]  Sandeep Jain,et al.  Palliative Hypo-fractionated Radiotherapy in Locally Advanced Head and Neck Cancer with Fixed Neck Nodes , 2012, Iranian journal of cancer prevention.

[9]  L. Dawson,et al.  Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma. , 2011, International journal of radiation oncology, biology, physics.

[10]  P. Levendag,et al.  Hypofractionated radiotherapy denoted as the “Christie scheme”: An effective means of palliating patients with head and neck cancers not suitable for curative treatment , 2009, Acta oncologica.

[11]  Srinivasan Vijayakumar,et al.  Palliative radiation therapy for head and neck cancer: Toward an optimal fractionation scheme , 2008, Head & neck.

[12]  P. Pai,et al.  Hypofractionated, palliative radiotherapy for advanced head and neck cancer. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  C. Bokemeyer,et al.  Platinum-based chemotherapy plus cetuximab in head and neck cancer. , 2008, The New England journal of medicine.

[14]  B. Hickey,et al.  Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial". , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  L. Peters,et al.  The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  B. Mohanti,et al.  Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  B. Jose,et al.  Phase I-II study of multiple daily fractions for palliation of advanced head and neck malignancies. , 1993, International journal of radiation oncology, biology, physics.

[18]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.